^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Squamous Cell Skin Cancer
    Drug:carboplatin (Alkylating agent) +
    paclitaxel (Tubulin inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Squamous cell skin cancer: Useful in Certain Circumstances...Carboplatin ± paclitaxel....Other Recommended Regimens...Carboplatin + paclitaxel